Mode
Text Size
Log in / Sign up
N/A N=41 Randomized Treatment

Longitudinal Study of Dental Implant Therapy in HIV Positive Patients

Dental Implant

Enrolled (actual)
41
Serious AEs
0.0%
Results posted
May 2020
Primary outcome: Primary: Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects — 28; 25 implants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Astra implants (Device)
Age
Adult, Older Adult · 19+ yrs
Sex
All
Sponsor
University of Alabama at Birmingham
Primary completion
Apr 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects
25; 17
PRIMARY
Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects
25; 17
PRIMARY
Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects
25; 17
SECONDARY
Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects
0.44; 0.48
SECONDARY
Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects
0.44; 0.48
SECONDARY
Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects
0.44; 0.48

Summary

The purpose is to place implants in HIV positive and HIV negative patients then follow patients over 3 years period of time to evaluate how well dental implants perform in HIV positive patients versus HIV negative patients.

Eligibility Criteria

Inclusion Criteria

  • Healthy enough to undergo the proposed therapy without compromise to existing health status
  • At least 19 years old
  • Able to read and understand written English without the aid of ad hoc interpretation
  • Able to cognitively understand the proposed study and therapy and possible prognoses
  • Able to consent for their own inclusion in the study.
  • Implant supported restorations are limited to the following edentulous areas: Mandibular arch (excluding 2nd and 3rd molar areas), Maxillary anterior and premolar areas

Exclusion Criteria

  • Smoker
  • Uncontrolled diabetes
  • Uncontrolled hypertension
  • Bisphosphonate user
  • Bruxer
  • Extraction site healed less than 6 months
  • Women pregnant or lactating at the time of enrollment
  • Previous malignant neoplasm
  • A known hypersensitivity to Titanium metal
  • Any medication/condition that in the opinion of the clinical investigators may adversely affect bone healing
  • Any indication of an inability to make autonomous decisions
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01211288). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search